TY - CHAP M1 - Book, Section TI - Effects of Drugs and Substances on Lactation and Infants A1 - Gomella, Tricia Lacy A1 - Cunningham, M. Douglas A1 - Eyal, Fabien G. A1 - Tuttle, Deborah J. PY - 2013 T2 - Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs, 7e AB - The chapter provides some summary data on medications and substances that may be taken by the mother during pregnancy and/or breast-feeding. Regardless of the designated risk category or presumed safety, no drug or substance should be used during pregnancy and/or breast-feeding unless it is clearly needed and the potential benefits clearly outweigh the risks. The table lists the generic medication name and, in parentheses, the Food and Drug Administration (FDA) fetal risk category followed by the breast-feeding compatibility. At the present time there is no formally FDA-sanctioned breast-feeding category, and the system used here is discussed later. Lastly, any reported effects on lactation or on infant effects based on breast milk consumption are noted. The editorial board has made an attempt to summarize the data based on the best information available for an individual agent where sources disagree. These data are subject to change as new information becomes available. The reader is advised to consult the FDA (www.fda.gov) and manufacturer's web site for the latest information concerning risks of these medications. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/14 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1107527124 ER -